As a professional with a background in Medical Biotechnology, I am passionate about communicating these complex scientific advancements in a clear and accessible way through high-quality writing
In recent years, GSH has emerged as a promising therapeutic trigger and biomarker, driving the development of nanotechnology-enabled platforms for controlled drug release, imaging, and theranostics
In general, treatments performed every 34 weeks are often recommended to maximize and maintain results
28 (7-8):753-6 Yasushi Honda, Takaomi Kessoku, Yoshio Sumida, Takashi Kobayashi, Takayuki Kato, Yuji Ogawa, Wataru Tomeno, Kento Imajo, Koji Fujita, Masato Yoneda, Koshi Kataoka, Masataka Taguri, Takeharu Yamanaka, Yuya Seko, Saiyu Tanaka, Satoru Saito, Masafumi Ono, Satoshi Oeda, Yuichiro Eguchi, Wataru Aoi, Kenji Sato, Yoshito Itoh, and Atsushi Nakajima - Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot study - BMC Gastroenterol
Inhibin inactivation in female mice leads to elevated FSH levels, ovarian overstimulation, and pregnancy loss
